APPLICATION
ANDA216608
TYPE
ANDA
ORIGINAL APPROVAL
2024-12-03
LATEST ACTION
2024-12-03
ROUTE
INTRAMUSCULAR
DOSAGE FORM
FOR SUSPENSION, EXTENDED RELEASE
MARKETING STATUS
Discontinued
Products
ARIPIPRAZOLEDiscontinued
ARIPIPRAZOLE 300MG/VIAL · FOR SUSPENSION, EXTENDED RELEASE · INTRAMUSCULAR
ARIPIPRAZOLEDiscontinued
ARIPIPRAZOLE 400MG/VIAL · FOR SUSPENSION, EXTENDED RELEASE · INTRAMUSCULAR
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.